Final Program
4njPuP
4njPuP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
354 WEDNESDAY • MAY 18<br />
720 Repeated Short-Term Exposures to Normobaric Hypoxia Do<br />
Not Prevent Acute Mountain Sickness in Susceptible<br />
Individuals/M. Faulhaber, E. Pocecco, H. Gatterer, T. Duennwald,<br />
N. Netzer, M. Burtscher, Innsbruck, Austria, p.A6654<br />
721 Sleep and Breathing of Healthy Young Adults in Normobaric<br />
Hypoxia Equivalent to 3500m, 4500m and 5500m Altitude:<br />
Physiologic Analysis and Description of Sex Differences/N.<br />
Netzer, S. Wimmer, M. Faulhaber, H. Gatterer, M. Burtscher, S.<br />
Pramsohler, Bad Aibling, Germany, p.A6655<br />
D30<br />
POSTER DISCUSSION SESSION<br />
NOVEL CLINICAL APPROACHES TO THORACIC<br />
MALIGNANCIES<br />
9:00 a.m. - 11:00 a.m. MOSCONE CENTER<br />
Room 309 (South Building, Esplanade Level)<br />
Poster Viewing 9:00-9:45<br />
Discussion 9:45-11:00<br />
Chairing: G.L. Narsavage, APRN, PhD, RN, Morgantown, WV<br />
T.J. Harkin, MD, New York, NY<br />
301 Clinical Contributions of Exhaled Volatile Organic Compounds<br />
in the Diagnosis of Lung Cancer/T. Oguma, T. Nagaoka, M.<br />
Kurahashi, N. Kobayashi, H. Takiguchi, K. Niimi, H. Tomomatsu, K.<br />
Tomomatsu, N. Hayama, T. Aoki, T. Urano, T. Abe, K. Asano,<br />
Kanagawa, Japan, p.A6656<br />
302 Is There an Association of One’s Clinical Phenotype with the<br />
Lung Cancer Phenotype They Are Most Likely to Develop?/P.<br />
Mazzone, X.-F. Wang, H. Choi, D. Ha, C. Chevalier, E. Shen, B.<br />
Huang, M.K. Gould, Cleveland, OH, p.A6657<br />
303 A Comparison of Lung Cancer in New Zealand Europeans and<br />
Maori: Are Maori More Susceptible to Smoking?/R.J. Hopkins,<br />
C. Kendall, G.D. Gamble, R.P. Young, Auckland, New Zealand,<br />
p.A6658<br />
304 Circulating Stanniocalcin-1 in the Diagnosis of Lung Cancer/V.<br />
Ifeacho, A. Ryazantsev, G. Rubiaco, M. Risco, O. James, K.<br />
Almodovar, D. Upadhyay, Fresno, CA, p.A6659<br />
305 Comorbidities Are Associated with Stage I Lung Cancer<br />
Diagnosis/M.C. Aldrich, H.M. Munro, E.L. Grogan, P.P. Massion,<br />
W.J. Blot, Nashville, TN, p.A6660<br />
306 Defining the Lung Cancer Comorbidome and Its Effect on<br />
Survival/M.K. Gould, E.E. Hahn, C.E. Munoz-Plaza, J.S. Lee, C.<br />
Parry, E. Shen, Pasadena, CA, p.A6661<br />
307 The Effect of Statins on Survival in Patients with Stage IV Lung<br />
Cancer/J.J. Lin, N. Ezer, K. Sigel, G. Mhango, J.P. Wisnivesky,<br />
New York, NY, p.A6662<br />
308 Lepidic Growth Component and Nodal Metastasis of Invasive<br />
Pulmonary Adenocarcinoma/J. Kim, K.W. Lee, Seongnam-si,<br />
Korea, Republic of, p.A6663<br />
309 Unique Clinical and Survival Characteristics of Clinically N0 on<br />
18F-FDG PET/CT in Stage IV Non-Small Cell Lung Cancer/<br />
J.H. Mok, S.M. Jang, H.J. Na, J.S. Eom, E.J. Jo, M.H. Kim, K. Lee,<br />
K.U. Kim, H.-K. Park, M.K. Lee, 602-739, Busan, Korea, Republic<br />
of, p.A6664<br />
310 Predictor of Mortality in Patients with Solid Malignancy<br />
Admitted to the ICU - A Prospective Observational Study/P.L.<br />
Kingah, Houston, TX, p.A6665<br />
311 Characterization and Prognosis of Non-Small Cell Lung Cancer<br />
(NSCLC) Patients with Secondary and Multiple Malignant<br />
Neoplasms/A.B. Schulze, L.H. Schmidt, A. Kuemmel, L.C. Baie, C.<br />
Albers, M. Mohr, A. Faldum, D. Goerlich, R. Wiewrodt, Muenster,<br />
Germany, p.A6666<br />
312 Napsin A Levels in Epithelial Lining Fluids in Patients with<br />
Primary Lung Adenocarcinoma/A. Uchida, T. Samukawa, T.<br />
Kumamoto, H. Mataki, K. Mizuno, I. Higashimoto, H. Inoue,<br />
Kagoshima, Japan, p.A6667<br />
313 The Accuracy of Quantitative CT Scan Based Prediction of<br />
Post-Lung Resection FEV1 and DLCO /H. Choi, D. Teeters, D.<br />
Raymond, P. Raffy, X. Wang, P. Mazzone, Cleveland, OH, p.A6668<br />
314 High Temperature Requirement A3 (HtrA3) Inhibits Cell<br />
Migration and Predicts Survival in Resected Non-Small-Cell<br />
Lung Cancer/J. Zhao, J. Zhang, M. Feng, J. Qu, Shanghai, China,<br />
p.A6669<br />
315 Analysis of Postoperative Survival in Patients with Resected<br />
Lung Adenocarcinoma According to the Tumor-Associated<br />
Macrophages/Y. Machida, N. Motono, M. Tanaka, S. Maeda, K.<br />
Usuda, M. Sagawa, Ishikawa, Japan, p.A6670<br />
316 Video-Assisted Thoracoscopic Surgery Vs Surgical<br />
Lobectomy: A Propensity Matched Study of Data from<br />
2008-2012/H.H. Desai, B. Natt, C. Bime, Tucson, AZ, p.A6671<br />
317 Use of 4DCT in the Measurement of Respiration-Induced<br />
Catheter Motion in Endobronchial High Dose Rate<br />
Brachytherapy/C. Parks, S. Cavanaugh, A. Vidovic, T. Law, S.<br />
Crawford, J. Wei, Newnan, GA, p.A6672<br />
318 Radiological Changes After Stereotactic Ablative Radiotherapy<br />
for Early Stage Lung Cancer: Observed Features of Fibrosis<br />
and Tumour Recurrence/A. Talwar, N. Panakis, N.M. Rahman, F.<br />
Gleeson, Oxford, United Kingdom, p.A6673<br />
319 Amrubicin for Relapsed Small-Cell Lung Cancer: A Systematic<br />
Review and Meta-Analysis of 803 Patients/K. Nakashima, N.<br />
Horita, A. Narita, M. Ikeda, R. Ushio, H. Watanabe, K. Nagai, Y.<br />
Shibata, K. Tashiro, H. Nagakura, T. Tsukahara, M. Yamamoto, T.<br />
Sato, T. Kaneko, Yokohama, Japan, p.A6674<br />
320 Does EGFR Mutation or Younger Age (Age£50 Years) Affect<br />
EGFR TKI Treatment Outcome? - A Cohort Study Among Lung<br />
Adenocarcinoma Patients in Taiwan/S.-G. Wu, C.-J. Yu, J.C.-H.<br />
Yang, J.-Y. Shih, P.-C. Yang, Douliou City, Taiwan, p.A6675<br />
321 Efficacy, Safety and Dosage of Afatinib in Patients with<br />
Non-Small Cell Lung Cancer After Failure of Prior Epidermal<br />
Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)/<br />
C. Park, T. Kim, H. Shin, H. Ban, J. Lim, Y. Kwon, I. Oh, S. Lim, Y.<br />
Kim, Hawsun, Jeonnam, Korea, Republic of, p.A6676<br />
ATS 2016 • San Francisco
Change language